scholarly journals High levels of depressive symptoms among people with lower limb lymphoedema in Rwanda: a cross-sectional study

2020 ◽  
Vol 114 (12) ◽  
pp. 974-982
Author(s):  
Maya Semrau ◽  
Gail Davey ◽  
Ursin Bayisenge ◽  
Kebede Deribe
Keyword(s):  
Depressive Symptoms ◽  
Lower Limb ◽  
Strong Predictor ◽  
Severe Depression ◽  
Female Gender ◽  
Cross Sectional Study ◽  
Disease Stage ◽  
Cluster Sampling ◽  
Cross Sectional ◽  
Patient Health

Abstract Background There is a growing body of evidence that mental distress and disorder are common among people with lower limb lymphoedema, although no research has been conducted on this subject in Rwanda. Methods This research was embedded within a mapping study to determine the national prevalence and geographical distribution of podoconiosis in Rwanda. Using a cluster sampling design, adult members of households within 80 randomly selected sectors in all 30 districts of Rwanda were first screened and 1143 patients were diagnosed with either podoconiosis (n=914) or lower limb lymphoedema of another cause (n=229). These 1143 participants completed the Patient Health Questionnaire (PHQ)-9 to establish the prevalence of depressive symptoms. Results Overall, 68.5% of participants reported depressive symptoms- 34.3% had mild depressive symptoms, 24.2% had moderate, 8.8% moderately severe and 1.2% severe depressive symptoms. The mean PHQ-9 score was 7.39 (SD=5.29) out of a possible 0 (no depression) to 27 (severe depression). Linear regression showed unemployment to be a consistently strong predictor of depressive symptoms; the other predictors were region (province), type of lymphoedema and, for those with podoconiosis, female gender, marital status and disease stage. Conclusions Levels of depressive symptoms were very high among people with lower limb lymphoedema in Rwanda, which should be addressed through holistic morbidity management and disability prevention services that integrate mental health, psychosocial and economic interventions alongside physical care.

scholarly journals Depressive Symptoms Amongst People with Podoconiosis and Lower Limb Lymphoedema of Other Cause in Cameroon: A Cross-Sectional Study

2019 ◽  
Vol 4 (3) ◽  
pp. 102 ◽  
Author(s):  
Maya Semrau ◽  
Gail Davey ◽  
Amuam Andrew Beng ◽  
Winston Patrick Chounna Ndongmo ◽  
Abdel Jelil Njouendou ◽  
...  
Keyword(s):  
Depressive Symptoms ◽  
Lower Limb ◽  
Mental Distress ◽  
Neglected Tropical Diseases ◽  
Psychosocial Interventions ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Cross Sectional ◽  
Patient Health ◽  
The Mean

Evidence is emerging that shows elevated mental distress and disorder amongst people with several neglected tropical diseases (NTDs). This study aimed to establish the prevalence of depressive symptoms amongst people with podoconiosis and lower limb lymphoedema of other cause in Cameroon. The study was part of a larger research piece that mapped the geographical distribution of podoconiosis in Cameroon. The Patient Health Questionnaire (PHQ-9; mean) was employed to determine the prevalence of depressive symptoms amongst people with lower limb lymphoedema. Linear regression was used to assess the association between socio-demographic characteristics of participants and depressive symptoms. Internal consistency of the PHQ-9 was estimated through Cronbach’s alpha (α = 0.651). The mean PHQ-9 score among people with lower limb lymphoedema was 3.48 (SD ± 3.25). Using a PHQ-9 score of 5 or above as the cut-off score, 32 participants (38.6%) displayed at least mild depressive symptoms. Unemployment was the only factor that was significantly associated with more depressive symptoms overall. This study shows that depressive symptoms are common amongst people with lower limb lymphoedema in Cameroon. The findings provide support for the integration of psychosocial interventions into packages of care for the management of lower limb lymphoedema.

scholarly journals Depression during COVID-19 Pandemic in India: Findings from an Online Survey

2020 ◽  
Vol 06 (02) ◽  
pp. 16-21
Author(s):  
Tanu Anand ◽  
Keyword(s):  
Depressive Symptoms ◽  
Online Survey ◽  
Protective Factor ◽  
Family Income ◽  
Severe Depression ◽  
Female Gender ◽  
Cross Sectional Study ◽  
Cross Sectional ◽  
Symptoms Of Depression ◽  
Coronavirus Infection

Introduction: Unprecedented crisis of COVID-19 pandemic has generated uncertainties in minds of people thereby impacting their mental health. Global evidence supports rising trend of symptoms of depression among general population during the pandemic. Material and Method: It was a cross-sectional study conducted between April 15 and May 01, 2020. Data were collected using pre-structured questionnaire that was circulated through a web-based link via messages and mails. Depressive symptoms were assessed using Patient Health Questionnaire-9 (PHQ-9). Data were analyzed using SPSS version 23. Result: Out of the total 500 telephonic contacts who were sent the survey link, 478 had (95.6%) responded. There were 114 (23.8%), 64 (13.4%), 40 (8.4%) and 29 (6.1%) participants who were classified as having mild, moderate, moderately severe and severe depression respectively. Female gender, religion, education status, unemployment and professional occupation, income less than Rs. 20000 and more than Rs. 40000, ‘scare for coronavirus infection’ were found to be significantly associated with severity of depression (p<0.05). Adjusted analysis revealed that age was protective factor where as those who were scared from coronavirus infection were found to be two times more at risk of having symptoms of depression. Increasing family income was also associated with presence of depressive symptoms. Conclusions: The proportion of participants with depressive symptoms was 51.7%. There is a need for assessing psychosocial impact of COVID-19 among populations and communities in varied settings over a long period of time.

scholarly journals Psychopathology and Somatic Complaints: A Cross-Sectional Study with Portuguese Adults

Healthcare ◽  
2021 ◽  
Vol 9 (4) ◽  
pp. 478
Author(s):  
Joana Proença Becker ◽  
Rui Paixão ◽  
Manuel João Quartilho
Keyword(s):  
Early Detection ◽  
Short Form ◽  
Female Gender ◽  
Cross Sectional Study ◽  
Physical Symptoms ◽  
Brief Symptom Inventory ◽  
Cross Sectional ◽  
Psychopathological Symptoms ◽  
Patient Health ◽  
The Impact

(1) Background: Functional somatic symptoms (FSS) are physical symptoms that cannot be fully explained by medical diagnosis, injuries, and medication intake. More than the presence of unexplained symptoms, this condition is associated with functional disabilities, psychological distress, increased use of health services, and it has been linked to depressive and anxiety disorders. Recognizing the difficulty of diagnosing individuals with FSS and the impact on public health systems, this study aimed to verify the concomitant incidence of psychopathological symptoms and FSS in Portugal. (2) Methods: For this purpose, 93 psychosomatic outpatients (91.4% women with a mean age of 53.9 years old) and 101 subjects from the general population (74.3% women with 37.8 years old) were evaluated. The survey questionnaire included the 15-item Patient Health Questionnaire, the 20-Item Short Form Survey, the Brief Symptom Inventory, the Depression, Anxiety and Stress Scale, and questions on sociodemographic and clinical characteristics. (3) Results: Increases in FSS severity were correlated with higher rates of depression, anxiety, and stress symptoms. The findings also suggest that increased rates of FSS are associated with lower educational level and female gender. (4) Conclusion: Being aware of the relationship between FSS and psychopathological symptoms and the need to explore psychosocial issues during clinical interviews may favor early detection of these cases. The early detection of mental disorders is essential for individuals’ adherence to treatments, reflecting on healthcare costs.

scholarly journals AB1192 THE UNDERWORLD OF DEPRESSIVE SYMPTOMS IN RHEUMATIC DISEASES: OVERLOOKED, UNRECOGNIZED OR UNPERCEIVED?

2020 ◽  
Vol 79 (Suppl 1) ◽  
pp. 1886.2-1887
Author(s):  
F. Ingegnoli ◽  
T. Schioppo ◽  
T. Ubiali ◽  
V. Bollati ◽  
S. Ostuzzi ◽  
...  
Keyword(s):  
Depressive Symptoms ◽  
Rheumatic Diseases ◽  
Real Life ◽  
Severe Depression ◽  
Mild Depression ◽  
Cross Sectional ◽  
Online Study ◽  
Social Burden ◽  
Patient Health ◽  
The University

Background:The concomitant presence of depressive symptoms and rheumatic diseases (RDs) impose a considerable economic and social burden on the communities as they are associated with numerous deleterious outcomes such as increased mortality, work disability, higher disease activity and worsening physical function, higher pain levels and fatigue. Despite growing interest on depressive symptoms burden in RDs, current patient perception on this topic is unknown.Objectives:Italian patients with RDs were invited to participate in an online study gauging the presence and the perception of depressive symptoms using the Patient Health Questionnaire (PHQ-9).Methods:This was a cross-sectional no-profit online study to screen the presence and the perception of depressive symptoms in RDs patients. All participants gave their consent to complete the PHQ-9 and they were not remunerated. Completion was voluntary and anonymous. The PHQ-9 rates the frequency of symptoms over the past 2 weeks on a 0-3 Likert-type scale. It contains the following items: anhedonia, depressed mood, trouble sleeping, feeling tired, change inappetite, guilt or worthlessness, trouble concentrating, feeling slowed down or restless, and suicidal thoughts. Patients were stratified as: <4 not depressed, 5-9 sub-clinical or mild depression, 10-14 moderate depression, 15-19 moderately severe depression and 20-27 severe depression. The survey was disseminated by ALOMAR (Lombard Association for Rheumatic Diseases) between June and October 2019.Results:192 patients took part in the study: 170 female with median age 50 years. Among respondents only 35 (18.2%) were not depressed. Depression was sub-clinical or mild in 68 (35.4%), moderate in 42 (21.9%), moderately severe in 30 (15.6%), and severe in 17 (8.9%). 16 (8.3%) of respondents declared to have depressive symptoms and 7 of 16 were under psychiatric therapy.Moreover, patients were grouped according to diagnosis.124 respondents had inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis). 23 (18.5%) were not depressed. Depression was sub-clinical or mild in 41 (33%), moderate in 26 (21%), moderately severe in 21 (17%), and severe in 13 (10.5%). Among them, 8 (6.5%) declared to have depressive symptoms depressed and 3 of 8 were under psychiatric therapy.49 respondents had a connective tissue disease or vasculitis. 11 (22.5%) were not depressed. Depression was sub-clinical or mild in 19 (38.8%), moderate in 13 (26.5%), moderately severe in 2 (4%), and severe in 4 (8.2%). Among them, 3 (6%) declared to have depressive symptoms and 1 of 6 were under psychiatric therapy.19 respondents had other rheumatic diseases. 1 (5.3%) was not depressed. Depression was sub-clinical or mild in 8 (42.1%), moderate in 3 (15.8%), moderately severe in 7 (36.8%). Among them, 5 (26.3%) declared to be depressed and 3 of 5 were under psychiatric therapy.Conclusion:Our study confirmed that the overall real-life burden of depressive symptoms is relevant in all RDs. At the same time, these results highlighted that depressive symptoms are overlook by physicians and unperceived by patients since fewer that half of respondents (46.4%) had a clinical depression (PHQ-9>10). These results suggested that screening for depression should form part of the routine clinical assessment of RD patients.Acknowledgments:We thank the Lombard Association of Rheumatic Diseases (ALOMAR) for its contribution to design and disseminate the survey, the group that sustain systemic sclerosis (GILS), and the IT service of the University of Milan.Disclosure of Interests:Francesca Ingegnoli: None declared, Tommaso Schioppo: None declared, Tania Ubiali: None declared, Valentina Bollati: None declared, Silvia Ostuzzi: None declared, Massimiliano Buoli: None declared, Roberto Caporali Consultant of: AbbVie; Gilead Sciences, Inc.; Lilly; Merck Sharp & Dohme; Celgene; Bristol-Myers Squibb; Pfizer; UCB, Speakers bureau: Abbvie; Bristol-Myers Squibb; Celgene; Lilly; Gilead Sciences, Inc; MSD; Pfizer; Roche; UCB

scholarly journals Family functioning of elderly with depressive symptoms

2014 ◽  
Vol 48 (3) ◽  
pp. 469-476 ◽  
Author(s):  
Rosely Almeida Souza ◽  
Gislaine Desani da Costa ◽  
Cintia Hitomi Yamashita ◽  
Fernanda Amendola ◽  
Jaqueline Correa Gaspar ◽  
...  
Keyword(s):  
Depressive Symptoms ◽  
Family Functioning ◽  
Family Health ◽  
Female Gender ◽  
Well Being ◽  
The Elderly ◽  
Cross Sectional Study ◽  
Cross Sectional ◽  
Dysfunctional Family ◽  
The Family

Objective: To classify families of elderly with depressive symptoms regarding their functioning and to ascertain the presence of an association between these symptoms, family functioning and the characteristics of the elderly. Method: This was an observational, analytical, cross-sectional study performed with 33 teams of the Family Health Strategy in Dourados, MS. The sample consisted of 374 elderly divided into two groups (with and without depressive symptoms). The instruments for data collection were a sociodemographic instrument, the GeriatricDepression Scale (15 items) and the Family Apgar. Results: An association was observed between depressive symptoms and family dysfunction, female gender, four or more people living together, and physical inactivity. Conclusion: The functional family may represent effective support for the elderly with depressive symptoms, because it offers a comfortable environment that ensures the well-being of its members. The dysfunctional family can barely provide necessary care for the elderly, which can exacerbate depressive symptoms.


scholarly journals The prevalence of smartphone addiction and its correlation with depression among higher college of technology students, Oman

2020 ◽  
Vol 8 (5) ◽  
pp. 1833
Author(s):  
Adil M. AL Mahrooqi ◽  
Talal A. AL Agbari ◽  
Asma S. AL Shidhani
Keyword(s):  
Severe Depression ◽  
Cross Sectional Study ◽  
Depression Score ◽  
Smartphone Addiction ◽  
Short Version ◽  
Mild Depression ◽  
Cross Sectional ◽  
Technology Students ◽  
College Of Technology ◽  
Patient Health

Background: The aim of this study is to identify the prevalence of smartphone addiction and its correlation with depression among Higher College of Technology students in Oman.Methods: A cross-sectional study was conducted in the Higher College of Technology, Oman. A self-reported questionnaire was distributed electronically to students between January and February 2017. The questionnaire contained a validated short version of the smartphone addiction scale (SAS-SV) and a validated Arabic version of the Patient Health Questionnaire-9 (PHQ-9), along with a single question to self-assess smartphone addiction.Results: With a response rate of 86.2%, a total of 376 students were considered, of whom 34.6% were males and 65.4% were females, with an overall mean age of 20.9 years. This study showed that the prevalence of smartphone addiction in the study population using the SAS-SV was 63.8%; 88.3% of students were using their smartphones for four hours or more per day and 80% had been using smartphones for more than four years. The overall depression rate was 32.2%. As the total depression score increased by 1 point, the smartphone addiction score increased by 0.428 points (p<0.005). The prevalence of smartphone addiction was 54.9% among those who had no depression, 80.3% among those who had mild depression, 75.9% among those who had moderate depression, and 96.2% among those who have severe depression (p<0.005).Conclusions: This study shows high smartphone addiction levels based on SAS-SV scores and found a significant positive correlation between smartphone addiction score and depression scores.

Depressive Symptoms in Dialysis: Prevalence and Relationship with Uremia-Related Biochemical Parameters

2018 ◽  
Vol 46 (4) ◽  
pp. 286-291 ◽  
Author(s):  
Luigi Cirillo ◽  
Roberta Cutruzzulà ◽  
Chiara Somma ◽  
Marco Gregori ◽  
Giuseppe Cestone ◽  
...  
Keyword(s):  
Depressive Symptoms ◽  
Functional Impairment ◽  
Biochemical Parameter ◽  
Serum Levels ◽  
Cross Sectional Study ◽  
Dialysis Patients ◽  
Cross Sectional ◽  
Patient Health ◽  
Laboratory Variables ◽  
The Impact

Background: Depression is the most common psychiatric disorder in long-term dialysis patients and a risk factor for morbidity and mortality. Although there is a relevance of the issue in the dialysis setting, we still know little about possible relationships between depression and uraemia-related biochemical abnormalities. Our aims were to evaluate (1) the prevalence of depression in our haemodialysis (HD) and peritoneal dialysis (PD) population using a validated and easy-to-implement screening tool and (2) the association between depression and the main uraemia-related clinical and biochemical parameter changes. Methods: In this monocentric cross-sectional study, all patients of our centre with at least 3 months of dialysis were screened by Patient Health Questionnaire-9 (PHQ-9), a self-administered depression-screening questionnaire validated in dialysis setting. The impact of depressive symptoms on daily life was also assessed. We then analysed relationships between the PHQ-9-derived depressive score, functional impairment score, demographic, clinical and laboratory variables. Results: In our cohort of 145 patients, depressive symptoms were found in 69 patients (46%). Stratifying for severity, mild, moderate and severe grade accounted for 31, 13 and 2% respectively. Depressive symptoms affected 36% of patients on PD versus 52% of patients on HD. Moreover, the PD patients had significantly less functional impairment derived from depressive symptoms than the HD patients. Simple and multiple regression analysis identified serum phosphorus as the only uraemia-related laboratory parameter that was high statistically associated with depressive score. Conclusions: Using a reliable, simple and fast tool, we found that depressive symptoms affect almost half of dialysis patients, particularly so the HD cohort. Severity of depressive symptoms seems related to serum levels of phosphorus possibly because depression affects compliance to therapy.

scholarly journals Depressive symptoms and associated factors in medical interns at a tertiary hospital

2019 ◽  
Vol 25 ◽  
Author(s):  
Kaveshin Naidu ◽  
John R. Torline ◽  
Michelle Henry ◽  
Helena B. Thornton
Keyword(s):  
Depressive Symptoms ◽  
Antidepressant Medication ◽  
Female Gender ◽  
Tertiary Hospital ◽  
Cross Sectional Study ◽  
Subjective Feeling ◽  
Cross Sectional ◽  
Symptoms Of Depression ◽  
Previous Diagnosis ◽  
Medical Interns

Background: It is known that medical doctors suffer from increased rates of depression with medical interns being most at risk. Despite this, little is known about the prevalence of depression in interns in South Africa.Objectives: This study aimed to assess the prevalence of depressive symptoms in interns employed at Groote Schuur Hospital, a tertiary hospital in the Western Cape.Method: The study was a cross-sectional study. All 91 interns were invited to participate in the study and consenting interns were required to complete a demographic and related questionnaire and the Beck Depression Inventory 2 (BDI-2).Results: Fifty-four (59.3%) of all invited interns participated in the study. Twenty-two interns (40.7%) reported a BDI-2 score of 14 or greater, indicating at least mild self-reported symptoms of depression. Features associated with a BDI-2 score of 14 or greater, included female gender, a previous diagnosis of depression, seeing a psychotherapist and previously being on antidepressant medication during internship. Other features also significantly associated with higher BDI-2 scores included suicidal ideation, thoughts of emigration, wanting to leave medicine and using substances to cope. The most significant associated feature of high BDI-2 scores was a subjective feeling of being ‘burnt out’.Conclusion: Interns had a higher prevalence of depressive symptoms when compared to the general population. The feeling of being ‘burnt out’ was the most significant factor associated with the severity of depressive symptoms. It is imperative that the mental health of both medical students and newly qualified doctors be prioritised, supported and monitored.

scholarly journals High Prevalence of Poststroke Depression in Ischemic Stroke Patients in Ethiopia

2020 ◽  
Vol 2020 ◽  
pp. 1-6
Author(s):  
Fikru Tsehayneh ◽  
Abenet Tafesse
Keyword(s):  
Depressive Symptoms ◽  
Negative Impact ◽  
Significant Proportion ◽  
Cross Sectional Study ◽  
Screening Tools ◽  
Limited Information ◽  
Poststroke Depression ◽  
Stroke Patients ◽  
Cross Sectional ◽  
Patient Health

Background. There is limited information and research carried out regarding the prevalence of poststroke depression (PSD) in the study area. Psychiatric disorders complicate a significant proportion of patients suffering from stroke. This of course have a great negative impact on our knowledge about poststroke depression in Ethiopia, and poststroke depression complicates a significant number of stroke patients and their rehabilitation. Methods. A cross-sectional study on all patients aged above 18 years and diagnosed with stroke in the past two years who attended the neurology follow-up clinics of Tikur Anbessa Specialized Hospital (TASH) and Zewditu Memorial Hospital (ZMH) was done by using a structured questionnaire containing Patient Health Questionnaire-9 (PHQ-9) depression screening tool. Result. Of 84 patients who were eligible for the study, 32.2% of patients have depressive symptoms. Women (OR 0.001, 95% CI 0.12–0.87) and aphasic patients (OR 0.034, 95% CI 0.19–1.27) were more likely to have depressive symptoms. Conclusion. Depressive symptoms after stroke are common in Ethiopian patients. Our study demonstrates female and aphasic patients are more likely to screen positive for PSD. Hence, screening all poststroke patients with different screening tools is practical, and further studies are needed to assess the validity of these screening tools and also to assess PSD as a predictor of stroke outcome.

The burnout's prevalence among Tunisian military consultants in psychiatry

2017 ◽  
Vol 41 (S1) ◽  
pp. S406-S406
Author(s):  
H. Belhadj ◽  
W. Krir ◽  
C. Bencheikh ◽  
H. Elkefi ◽  
A. Oumaya
Keyword(s):  
Severe Depression ◽  
Cross Sectional Study ◽  
Burnout Syndrome ◽  
Short Version ◽  
Cross Sectional ◽  
Verbal Aggressiveness ◽  
Patient Health ◽  
Human Cost ◽  
Competing Interest ◽  
Military Patients

IntroductionBurnout causes a considerable human cost. Army employees are, in fact, particularly exposed to this risk.ObjectiveTo determinate the prevalence of burnout syndrome among military consultants in psychiatry and to study its socio-familial repercussions.MethodA cross-sectional study was conducted in a military outpatient clinic in Tunis and included 30 military patients with a seniority of more than 15 years. Burnout and major depression were assessed with the instrument Burnout Measure Short version (BMS-10) and the Patient Health Questionnaire “PHQ-9”, respectively.ResultsEighty percent of participants (n = 24) had a very high degree of burnout exposure according to BMS-10. Twenty of these (83.3%) had a moderate to severe depression. All married patients (n = 22) having burnout syndrome reported a conjugopathy and a tendency to physical and verbal aggressiveness against their children.ConclusionMilitary employees are particularly vulnerable to burnout. Detecting burnout in time is therefore essential in order to prevent its undeniable socio-familial repercussions.Disclosure of interestThe authors have not supplied their declaration of competing interest.

Sign in / Sign up

Export Citation Format

Share Document